Course 1: Health innovation and entrepreneurship, spring 2022

Learn how to turn research results and ideas into business ventures and how to create innovative services in a clinical setting. 

Image may contain: White-collar worker, Design, Conversation, Event, Room.

This course will equip medical, healthcare and life science researchers with tools and knowledge to innovate services for patients, create companies based on their research ideas, or bring their research ideas into existing companies.

You will meet with and learn from leaders in academia, hospitals and healthcare companies. You can find the programme here (pdf)

The course is free of charge and covered by a grant from the Novo Nordisk foundation. Travel and accommodation is also covered. The teaching language throughout the course is English. 


Case-based learning is a core part of the programme, and cases are developed in collaboration between the partnering universities and companies presenting in the programme. Project-based learning is another central part of the programme, where the participants are given the opportunity to develop an idea from their own research environment.


The School of Health Innovation is a Scandinavian programme open for PhD:s and postdocs from Faculty of medicine at UiO, NTNU, KI, KU and any other Nordic universities.

The number of students is limited to 60 and admission is based on CV (2-pages in pdf), motivational letter (1 page in pdf) and supervisor recommendation letter (1 page in pdf).

Practical issues and expenses

There is no course fee. The course gives 7.5 ECTS. The course will physical with modules in Oslo, Copenhagen and Karolinska.

Learning outcomes

  • After completion of the course the participants will be able to:
  • Learn how to build a business in healthcare based on their own research
  • Demonstrate an understanding of the opportunities of health innovation and entrepreneurship for utilization of research
  • Apply scientific background and new knowledge of health innovation to address challenges and develop services and products within a clinical setting and a biopharma/medtech setting
  • Use various business tools for ideation and feasibility studies; to develop, prototype and test solutions in response to user needs
  • Develop a business plan based upon a novel idea and communicate a business plan to people within the startup world
  • Demonstrate an understanding of how Tech Transfer Offices and other innovation support actors can support the commercialization process
  • Discuss and argue for different types of intellectual property and intellectual assets, and understand different patent strategies
  • Apply the basics in financing a startup company from private and governmental funding bodies
  • Discuss and argue for different types of intellectual property and intellectual assets, and establish patent strategies
  • Assess their skills in health innovation and reflect on the exploitation of their own research
  • Combine being a scientist and a health innovator/entrepreneur


You must attend at least 80 per cent of the course in order to be allowed to take the exam. Attendance will be registered.

The examination will be based on the following:

  • Oral group presentations related to cases
  • Group innovation project presented at the end of the course.The project may be based from your own research or developed during the course.
  • Written individual report (2-3 pages) in which you reflect on your main learning outcomes from the course and how you may utilize this new learning in your career.

The grading is based on the pass/fail system.
The course gives 7.5 ECTS.


The course is a Nordic enterprise developed in partnership between:

  • The University of Oslo (UiO)
  • Norwegian University of Science and Technology (NTNU)
  • Karolinska Institutet (KI) in Stockholm
  • University of Copenhagen (KU)
  • The healthcare business clusters Nansen Neuroscience Network

The course is open to applicants from all collaborating universities and institutions in Norway, Sweden and Denmark.

The course is funded by a grant from the Novo Nordisk Foundation

Questions? Please contact:

Bjarte Reve:

Tonje Steigedal:

Samer Yammine:

Adrian Ramon Santonja:

Published Oct. 19, 2016 11:21 AM - Last modified Feb. 22, 2022 10:00 AM